Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
With a five-year survival rate under 9%, pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest tumors. Although the treatment options are slightly improving, PDAC is the second leading cause of cancer related death in 2020 in the US. In addition to a pronounced desmoplastic stroma...
Main Authors: | Claudia Geismann, Alexander Arlt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/11/2353 |
Similar Items
-
Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
by: Diego Camuzi, et al.
Published: (2019-04-01) -
Epigenetic Alterations in Pancreatic Cancer Metastasis
by: Sarah S. Wang, et al.
Published: (2021-07-01) -
Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
by: Mutian Lian, et al.
Published: (2023-12-01) -
Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
by: Joyce K. Thompson, et al.
Published: (2021-09-01) -
The Epigenetic Landscape of Pancreatic Cancer Stem Cells
by: Sladjana Zagorac, et al.
Published: (2018-06-01)